Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 57.2

(-5.61%)

Total Assets Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual total assets in 2023 was 828.57 Million TWD , up 31.34% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly total assets in 2024 Q2 was 753.68 Million TWD , down -6.15% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported annual total assets of 630.86 Million TWD in 2022, down -28.78% from previous year.
  • Energenesis Biomedical CO.,LTD. reported annual total assets of 885.81 Million TWD in 2021, up 25.57% from previous year.
  • Energenesis Biomedical CO.,LTD. reported quarterly total assets of 803.06 Million TWD for 2024 Q1, down -3.08% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported quarterly total assets of 887.5 Million TWD for 2023 Q3, down -6.56% from previous quarter.

Annual Total Assets Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Historical Annual Total Assets of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 828.57 Million TWD 31.34%
2022 630.86 Million TWD -28.78%
2021 885.81 Million TWD 25.57%
2020 705.44 Million TWD -13.29%
2019 813.6 Million TWD 0.0%

Peer Total Assets Comparison of Energenesis Biomedical CO.,LTD.

Name Total Assets Total Assets Difference
Apex Biotechnology Corp. 2.29 Billion TWD 63.928%
Sinphar Pharmaceutical Co.,Ltd. 6.25 Billion TWD 86.745%
Panion & Bf Biotech Inc. 3.23 Billion TWD 74.389%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 5.17 Billion TWD 83.979%
GenMont Biotech Incorporation 1.65 Billion TWD 49.88%
Abnova (Taiwan) Corporation 1.35 Billion TWD 38.884%
Adimmune Corporation 9.48 Billion TWD 91.264%
Tanvex BioPharma, Inc. 2.76 Billion TWD 70.016%
Polaris Group 9.09 Billion TWD 90.893%
UnicoCell Biomed Co., Ltd. 685.92 Million TWD -20.795%
PELL Bio-Med Technology Co. Ltd. 1.41 Billion TWD 41.574%